Paul DiComo, longtime Polk Audio and Definitive Technology sales and marketing manager, lost his battle with cancer and died peacefully with his wife Susan Putnam by his side on Friday, September 10, 2021.
Paul was born on January 24, 1951, to Charles and Lillian DiComo in Newark, New Jersey.
After college at Rutgers, Newark, he moved to Boston, cutting his audio and sales chops first at Waltham Camera and Stereo, then at Tweeter Etc, managing both the Chestnut Hill and Harvard Square locations.
In 1981, Paul joined the fledgling electronics group NAD as National Sales Manager. Two years later, he accepted the role of National Sales Manager at Polk, and in 1995 used his writing and industry relations skills as Marketing and Public Relations Manager. In both of these roles Paul was an important figure in the growth of Polk Audio from a small regional company to one of the largest of its type in the global market. Paul was recruited to Definitive Technology in 2007 as Senior Vice President of Marketing and New Product Development, a role he held until late 2013.
From January 2014 on, Paul, with partner Al Ballard, founded CE-Marketing Pros, LLC., a marketing agency helping established and start-up Consumer Electronics brands build market share and consumer awareness.
Paul was well known throughout the consumer electronics industry for his keen intellect, his passion for his work, but most of all for his larger-than-life personality and love of life. His laughter was infectious and his outgoing personality made him a natural fit for his many roles in the industry. As he travelled the US and the world, Paul gained the respect of many, and would freely share his love and passion for music and fine audio products.
He is survived by his beloved wife and life partner, Susan Putnam, and their sons Michael and Gregory as well as two grandchildren. A memorial in Paul’s honor will be held at the Candle Light funeral home in Catonsville, Maryland on Saturday, September 25th.
In lieu of flowers, contributions to MMRF (Multiple Myeloma Research Foundation) would be appreciated.